Feed / IQV

IQVIA Holdings Inc.

IQV

Healthcare · 257.34 +0.1% today

Participation confirmed · construction unavailableMarket checked 10 Sept, 15:55 GMT-4

Market read

IQVIA Holdings Inc.'s move is being confirmed by its market group.

The latest filing is mixed. 5 of 35 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.

What changed
  • Revenue increased 8.4% versus the comparable filing period.
  • Operating margin fell 0.6 percentage points.
Company+0.1% todayVolume comparison unavailable
Market group5 of 35 activeSoftware Stocks · inactive
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 23 of 35 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ASAN begins moving with the group.

Invalidation: The live read weakens if participation falls to 12 of 35 members or fewer.

Watch this read

Research brief

The story so far

Healthcare · Diagnostics & Research

The latest filing is mixed. 5 of 35 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 8.4% versus the comparable filing period.
Evidence that challenges
  • Operating margin fell 0.6 percentage points.
What would clarify the read
  • At least 23 of 35 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ASAN begins moving with the group.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations601
Usable filing statements122
Verified relationships14
Evidence supporting the case
  • Latest annual revenue changed +5.9% year over year.
  • Credit and interest rates has repeated favorable evidence across 5 filings.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

257.34
6m+50.0%12m+35.7%24m+3.9%
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$13.9B+22.1%$4.95+0.0%
2022-12-31$14.4B+3.9%$5.72-2.3%
2023-12-31$15.0B+4.0%$7.29-2.3%
2024-12-31$15.4B+2.8%$7.49-1.6%
2025-12-31$16.3B+5.9%$7.84-5.4%

What management says matters

Persistent and emerging business drivers

Credit and interest ratespositive · 5 filings
Interest expense during the three and six months ended June 30, 2026 increased compared to the same periods in 2025 as a result of higher outstanding debt balances.
10-Q · Jul 28, 2026
Restructuring and cost reductionspositive · 5 filings
Restructuring Costs Three Months Ended June 30, Six Months Ended June 30, (in millions) 2026 2025 2026 2025 Restructuring costs $ 63 $ 32 $ 114 $ 61 The restructuring costs incurred during 2026 and 2025 were due to ongoing efforts to streamline our global ope…
10-Q · Jul 28, 2026
Legal and regulatory exposurepositive · 2 filings
In January 2026, the OECD released Administrative Guidance establishing a “side‑by‑side” system that is intended to reduce the compliance burden of calculating the Pillar 2 top-up-tax amounts for jurisdictions with similar regimes with minimum tax requirement…
10-Q · May 5, 2026
Foreign exchangepositive · 1 filings
The valuation allowance increased primarily due to current year state tax expenses on foreign exchange revaluations on debt instruments offset by use of U.S.
10-K · Feb 17, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.7× · EV/sales 3.5×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

257.34+0.1% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for IQV. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

The latest filing presents a mixed picture

10-Q filed 2026-05-05 against the comparable filing from 2025-05-06.

mixed
OperationsmixedEvidence score 0
liquidityneutralEvidence score 0
valuationmixed

What improved

  • Revenue increased 8.4% versus the comparable filing period.

What weakened

  • Operating margin fell 0.6 percentage points.

Filing receipts

Cash Flow from Investing Activities Three Months Ended March 31, (in millions) 2026 2025 Net cash used in investing activities $ (196) $ (305) Cash used in investing activities decreased $109 million during the first three months of 2026 as compared to the same period in 2025, primarily driven by less cash used for acquisitions of businesses ($97 million), cash used for investments in debt and equity securities ($19 million), cash used for acquisitions of property, equipment and software ($15 million), and cash from other ($1 million), offset by more cash used for investments in unconsolidated affiliates, net ($22 million) and cash from sales of marketable securities, net ($1 million).

Cash Flow from Financing Activities Three Months Ended March 31, (in millions) 2026 2025 Net cash used in financing activities $ (433) $ (258) Cash used in financing activities increased $175 million during the first three months of 2026 as compared to the same period in 2025, primarily due to less proceeds from issuance of debt, net ($1,333 million), more cash used for repurchase of common stock ($177 million), less proceeds from revolving credit facilities, net of repayments ($75 million), and more cash used for payments related to employee stock incentive plans ($5 million), offset by less cash payments for debt and principal payments on finance leases ($1,413 million) and contingent con...

The constant currency revenue growth for the three months ended March 31, 2026 was primarily driven by an increase in patient solutions (formerly included in real-world solutions), and to a lesser extent by information services and commercial engagement services (formerly included in contract sales and medical solutions).

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind IQV

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ACNAccenture plccompetitorFeb 17, 2026

Our offerings compete with various firms, including Accenture, Aetion (a Datavant company), Panalgo (a Norstella company), Cognizant Technology Solutions, Deloitte, Pharmaceutical Product Development, Inc.

CLVTClarivate PlccompetitorFeb 17, 2026

Our offerings compete with various firms, including Accenture, Aetion (a Datavant company), Panalgo (a Norstella company), Cognizant Technology Solutions, Deloitte, Pharmaceutical Product Development, Inc.

Depended on by

VEEVVeeva Systems Inc.competitorJun 5, 2026

IQVIA, which historically offered a competitive CRM solution, has licensed its CRM software to Salesforce.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

IQV is currently a Participant in the organic co-movement group Software Stocks. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.